Better methods are becoming available to more accurately define which patients are more likely to develop more aggressive disease. Gene profiling, also known as gene array analysis, is being identified as a helpful method of defining which people will respond to which medications. Studies are underway that are using gene array analysis methods to determine which patients will be at more risk for more aggressive disease. Finally, genetic research and engineering is likely to bring forth many new avenues for earlier diagnosis and accurate treatment in the near future. This is all occurring because of technology improvements. We are at the threshold of tremendous improvements in the way rheumatoid arthritis is managed.
In the future, medications may be available that can protect the cartilage from the deteriorating consequences of osteoarthritis. New treatments, such as antiinflammatory lotion and patches (diclofenac [Flector]) are becoming available for relief of joint pain symptoms. Innovative cartilage research will open the door for new approaches to an old problem. Investigators are evaluating the effectiveness of over-the-counter food supplements. Better treatment options are being developed as we understand more about our immune system and genetics.

While there is a strong genetic component to developing this form of diabetes, there are other risk factors - the most significant of which is obesity. There is a direct relationship between the degree of obesity and the risk of developing type 2 diabetes, and this holds true in children as well as adults. It is estimated that the chance to develop diabetes doubles for every 20% increase over desirable body weight.

Chemotherapy is the treatment of cancer with one or more cytotoxic anti-neoplastic drugs (chemotherapeutic agents) as part of a standardized regimen. The term encompasses a variety of drugs, which are divided into broad categories such as alkylating agents and antimetabolites.[144] Traditional chemotherapeutic agents act by killing cells that divide rapidly, a critical property of most cancer cells.


According to the U.S. National Library of Medicine, cannabis use for medicinal purposes dates back at least 3,000 years. It was introduced into Western medicine in the 1840s by W.B. O’Shaughnessy, a surgeon who learned of its medicinal properties while working in India for the British East Indies Co. It became useful because of its analgesic, sedative, anti-inflammatory, anti-spasmodic and anti-convulsant effects.
These policies vary widely. Marijuana and CBD are currently fully legal for both medicinal and recreational purposes in Alaska, California, Colorado, Maine, Massachusetts, Michigan, Nevada, Oregon, Vermont, Washington, and Washington D.C. In 23 states, it's legal in some form, such as for medicinal purposes. Another 14 states permit just CBD oil. But both are illegal in Idaho, Nebraska, and South Dakota. For more information, the organization Americans for Safe Access has a helpful guide to the specific laws in each state.
Better methods are becoming available to more accurately define which patients are more likely to develop more aggressive disease. Gene profiling, also known as gene array analysis, is being identified as a helpful method of defining which people will respond to which medications. Studies are underway that are using gene array analysis methods to determine which patients will be at more risk for more aggressive disease. Finally, genetic research and engineering is likely to bring forth many new avenues for earlier diagnosis and accurate treatment in the near future. This is all occurring because of technology improvements. We are at the threshold of tremendous improvements in the way rheumatoid arthritis is managed.

Cancer is caused by changes (mutations) to the DNA within cells. The DNA inside a cell is packaged into a large number of individual genes, each of which contains a set of instructions telling the cell what functions to perform, as well as how to grow and divide. Errors in the instructions can cause the cell to stop its normal function and may allow a cell to become cancerous.
Ionizing radiation is not a particularly strong mutagen.[51] Residential exposure to radon gas, for example, has similar cancer risks as passive smoking.[51] Radiation is a more potent source of cancer when combined with other cancer-causing agents, such as radon plus tobacco smoke.[51] Radiation can cause cancer in most parts of the body, in all animals and at any age. Children and adolescents are twice as likely to develop radiation-induced leukemia as adults; radiation exposure before birth has ten times the effect.[51]

Creatinine is a chemical waste molecule that is generated from muscle metabolism. Creatinine is produced from creatine, a molecule of major importance for energy production in muscles. Creatinine has been found to be a fairly reliable indicator of kidney function. As the kidneys become impaired the creatinine level in the blood will rise. Normal levels of creatinine in the blood vary from gender and age of the individual.
Symptoms and signs of cancer depend on the type of cancer, where it is located, and/or where the cancer cells have spread. For example, breast cancer may present as a lump in the breast or as nipple discharge while metastatic breast cancer may present with symptoms of pain (if spread to bones), extreme fatigue (lungs), or seizures (brain). A few patients show no signs or symptoms until the cancer is far advanced.
31 January 2019 ¦ GENEVA: Ahead of World Cancer Day (4 February), the World Health Organization (WHO) has released new guidance on managing cancer pain, with a view to improving the health sector response and ending the needless suffering of cancer patients. Around the world, pain is experienced by more than half (55%) of patients undergoing treatment for cancer and two thirds (66%) of people with advanced or terminal cancer. The WHO Guidelines for the pharmacologic and radiotherapeutic management of cancer pain in adults and adolescents provide evidence-based guidance to health-care providers on appropriate approaches to the medical and radiotherapeutic management of cancer pain. This includes guidance on the choice of analgesic medicines (painkillers); the use of adjuvant medicines (steroids), and specific techniques for treating pain from bone metastases (bisphosphonates and radiotherapy).
The base of so many great cannabis products starts with great cannabis oil. At Caliva, we invest in innovation and utilize cutting-edge oil extraction and refinement technology to to produce high purity cannabis oil. Our team of cultivators, scientists, and artisan formulators work together to produce the perfect oil blend to fit your product development needs. From vape cartridges, to specialty topicals, edibles and tincture, our oil formulations serve as the basis for high quality cannabis products. All Caliva oils are tested to 2018 California state standards. Our oil is sold by the kilo only and shipped in laboratory grade glass. 
×